RU2017136720A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017136720A3 RU2017136720A3 RU2017136720A RU2017136720A RU2017136720A3 RU 2017136720 A3 RU2017136720 A3 RU 2017136720A3 RU 2017136720 A RU2017136720 A RU 2017136720A RU 2017136720 A RU2017136720 A RU 2017136720A RU 2017136720 A3 RU2017136720 A3 RU 2017136720A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6919—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a ribbon or a tubule cochleate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010138070 | 2010-06-17 | ||
| JP2010-138070 | 2010-06-17 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013101969A Division RU2635460C2 (ru) | 2010-06-17 | 2011-06-17 | Средство для лечения фиброза почек |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017136720A3 true RU2017136720A3 (ru) | 2019-02-08 |
| RU2017136720A RU2017136720A (ru) | 2019-02-08 |
| RU2711531C2 RU2711531C2 (ru) | 2020-01-17 |
Family
ID=45348325
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013101969A RU2635460C2 (ru) | 2010-06-17 | 2011-06-17 | Средство для лечения фиброза почек |
| RU2017136720A RU2711531C2 (ru) | 2010-06-17 | 2011-06-17 | Средство для лечения фиброза почек |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013101969A RU2635460C2 (ru) | 2010-06-17 | 2011-06-17 | Средство для лечения фиброза почек |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20130136789A1 (ru) |
| EP (1) | EP2583691B1 (ru) |
| JP (2) | JP2012020995A (ru) |
| KR (1) | KR101967868B1 (ru) |
| CN (1) | CN102933233A (ru) |
| AU (1) | AU2011266057B2 (ru) |
| CA (1) | CA2802414C (ru) |
| ES (1) | ES2712086T3 (ru) |
| IN (1) | IN2013CN00342A (ru) |
| RU (2) | RU2635460C2 (ru) |
| TW (1) | TWI549691B (ru) |
| WO (1) | WO2011158933A1 (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009221164A (ja) | 2008-03-17 | 2009-10-01 | Nitto Denko Corp | 肺線維症処置剤 |
| US9572886B2 (en) | 2005-12-22 | 2017-02-21 | Nitto Denko Corporation | Agent for treating myelofibrosis |
| JP5950428B2 (ja) * | 2010-08-05 | 2016-07-13 | 日東電工株式会社 | 線維化組織から正常組織を再生するための組成物 |
| JP6340162B2 (ja) | 2012-12-20 | 2018-06-06 | 日東電工株式会社 | アポトーシス誘導剤 |
| WO2014113695A1 (en) * | 2013-01-18 | 2014-07-24 | Cornell University | Methods of treating diseases associated with high fat diet and vitamin a deficiency using retinoic acid receptor agonists |
| ES2821966T3 (es) | 2014-04-02 | 2021-04-28 | Nitto Denko Corp | Molécula de direccionamiento derivada de RBP y utilización de la misma |
| CN106133024B (zh) | 2014-04-07 | 2019-07-05 | 日东电工株式会社 | 用于疏水性药物递送的新颖的基于聚合物的助水溶物 |
| CN105597085A (zh) * | 2015-12-17 | 2016-05-25 | 哈尔滨博翱生物医药技术开发有限公司 | 成纤维细胞生长因子-21在治疗肾纤维化中的应用 |
| JP6833456B2 (ja) * | 2016-11-02 | 2021-02-24 | 日東電工株式会社 | 皮膚線維症処置剤 |
| KR102352489B1 (ko) | 2019-12-09 | 2022-01-18 | 전남대학교산학협력단 | 소수성 개질된 글리콜 키토산 나노입자 및 이를 이용한 신장 표적화 약물 전달체 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5238924A (en) | 1984-05-03 | 1993-08-24 | Merck & Co., Inc. | Treatment of renal diseases with ace inhibitors |
| JP3810020B2 (ja) | 1993-04-22 | 2006-08-16 | 武田薬品工業株式会社 | 腎疾患の予防または治療剤 |
| US6183774B1 (en) * | 1996-01-31 | 2001-02-06 | Collaborative Laboratories, Inc. | Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts |
| US6334999B1 (en) * | 1999-08-27 | 2002-01-01 | Research Development Foundation | Liposomal aerosols for delivery of chemotherapeutic retinoids to the lungs |
| IL141120A0 (en) | 2000-01-31 | 2002-02-10 | Pfizer Prod Inc | Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure |
| BR0006556A (pt) * | 2000-12-28 | 2002-09-17 | Apsen Farmaceutica S A | Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose |
| IL143366A0 (en) | 2001-05-24 | 2002-04-21 | Harasit Medical Res Services & | Treatment of renal fibrosis |
| JP2004043459A (ja) | 2002-05-24 | 2004-02-12 | Sumitomo Pharmaceut Co Ltd | ＴＧＦ−β阻害活性を有する低分子化合物からなる医薬 |
| EP1454625A1 (en) | 2003-03-06 | 2004-09-08 | Speedel Development AG | Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies |
| EP1746885A4 (en) | 2004-05-03 | 2010-09-08 | Univ Virginia | ADENOSINE A2A RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETIC NEPHROPATHY |
| KR100613342B1 (ko) | 2004-12-16 | 2006-08-21 | 동부일렉트로닉스 주식회사 | 반도체 소자 및 그 제조방법 |
| PL2727583T3 (pl) * | 2004-12-22 | 2022-02-07 | Nitto Denko Corporation | Nośnik leku i zestaw z nośnikiem leku do hamowania włóknienia |
| JP2009221164A (ja) * | 2008-03-17 | 2009-10-01 | Nitto Denko Corp | 肺線維症処置剤 |
| JP2007099641A (ja) | 2005-09-30 | 2007-04-19 | Tsumura & Co | インドールキノキサリン類化合物、その製造方法およびそれを用いた医薬組成物 |
| JP5342834B2 (ja) * | 2008-09-05 | 2013-11-13 | 日東電工株式会社 | 骨髄線維症処置剤 |
| JP2009292725A (ja) | 2006-09-01 | 2009-12-17 | Stelic Institute Of Regenerative Medicine | 腎疾患改善剤 |
| TWI407971B (zh) * | 2007-03-30 | 2013-09-11 | Nitto Denko Corp | Cancer cells and tumor-related fibroblasts |
| JP2009007258A (ja) | 2007-06-26 | 2009-01-15 | Kowa Pharmaceutical Co Ltd | Ｐａｉ−１産生抑制作用を有する３−アニリノ−２−シクロアルケノン誘導体 |
| JP2009029750A (ja) | 2007-07-27 | 2009-02-12 | Kowa Co | アリールプロパン誘導体を有効成分とする糖化最終産物形成阻害剤 |
| US8003621B2 (en) * | 2007-09-14 | 2011-08-23 | Nitto Denko Corporation | Drug carriers |
| JP2009178143A (ja) | 2008-02-01 | 2009-08-13 | Stelic Institute Of Regenerative Medicine | 脂肪性肝炎−肝癌モデル動物 |
| KR20140065017A (ko) * | 2008-07-30 | 2014-05-28 | 닛토덴코 가부시키가이샤 | 약물 담체 |
| TW201630627A (zh) * | 2008-09-12 | 2016-09-01 | 日東電工股份有限公司 | 纖維化疾病之造影劑 |
| JP2010077101A (ja) | 2008-09-29 | 2010-04-08 | Toray Ind Inc | 腎線維症の治療剤又は予防剤 |
| EP3434773A3 (en) * | 2009-12-09 | 2019-04-17 | Nitto Denko Corporation | Modulation of hsp47 expression |
| WO2012170952A2 (en) * | 2011-06-08 | 2012-12-13 | Nitto Denko Corporation | Compounds for targeting drug delivery and enhancing sirna activity |
-
2011
- 2011-06-17 KR KR1020137001156A patent/KR101967868B1/ko active IP Right Grant
- 2011-06-17 AU AU2011266057A patent/AU2011266057B2/en active Active
- 2011-06-17 CA CA2802414A patent/CA2802414C/en active Active
- 2011-06-17 ES ES11795835T patent/ES2712086T3/es active Active
- 2011-06-17 IN IN342CHN2013 patent/IN2013CN00342A/en unknown
- 2011-06-17 EP EP11795835.5A patent/EP2583691B1/en active Active
- 2011-06-17 CN CN2011800279298A patent/CN102933233A/zh active Pending
- 2011-06-17 JP JP2011134708A patent/JP2012020995A/ja active Pending
- 2011-06-17 RU RU2013101969A patent/RU2635460C2/ru active
- 2011-06-17 WO PCT/JP2011/063910 patent/WO2011158933A1/ja active Application Filing
- 2011-06-17 US US13/704,437 patent/US20130136789A1/en not_active Abandoned
- 2011-06-17 RU RU2017136720A patent/RU2711531C2/ru active
- 2011-06-17 TW TW100121244A patent/TWI549691B/zh active
-
2015
- 2015-03-25 US US14/668,618 patent/US20150259683A1/en not_active Abandoned
- 2015-05-18 JP JP2015100873A patent/JP5873589B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2635460C2 (ru) | 2017-11-13 |
| JP2015155459A (ja) | 2015-08-27 |
| RU2013101969A (ru) | 2014-07-27 |
| TWI549691B (zh) | 2016-09-21 |
| IN2013CN00342A (ru) | 2015-07-03 |
| JP2012020995A (ja) | 2012-02-02 |
| AU2011266057A1 (en) | 2013-01-10 |
| EP2583691A1 (en) | 2013-04-24 |
| EP2583691B1 (en) | 2019-01-16 |
| KR20130121813A (ko) | 2013-11-06 |
| WO2011158933A1 (ja) | 2011-12-22 |
| US20150259683A1 (en) | 2015-09-17 |
| US20130136789A1 (en) | 2013-05-30 |
| TW201204389A (en) | 2012-02-01 |
| RU2017136720A (ru) | 2019-02-08 |
| EP2583691A4 (en) | 2016-04-27 |
| JP5873589B2 (ja) | 2016-03-01 |
| CA2802414C (en) | 2018-01-09 |
| ES2712086T3 (es) | 2019-05-09 |
| CA2802414A1 (en) | 2011-12-22 |
| RU2711531C2 (ru) | 2020-01-17 |
| CN102933233A (zh) | 2013-02-13 |
| AU2011266057B2 (en) | 2014-12-04 |
| KR101967868B1 (ko) | 2019-08-19 |